Inari Medical Inc. (NARI)
Inari Medical Statistics
Share Statistics
Inari Medical has 58.56M shares outstanding. The number of shares has increased by 0.73% in one year.
| Shares Outstanding | 58.56M |
| Shares Change (YoY) | 0.73% |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | 93.59% |
| Shares Floating | 53.34M |
| Failed to Deliver (FTD) Shares | 100 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -2252.78 and the forward PE ratio is null. Inari Medical's PEG ratio is 23.77.
| PE Ratio | -2252.78 |
| Forward PE | n/a |
| PS Ratio | 7.47 |
| Forward PS | 4.2 |
| PB Ratio | 7.93 |
| P/FCF Ratio | 123.98 |
| PEG Ratio | 23.77 |
Enterprise Valuation
Inari Medical has an Enterprise Value (EV) of 3.68B.
| EV / Sales | 7.45 |
| EV / EBITDA | 242.25 |
| EV / EBIT | 102.4 |
| EV / FCF | 123.76 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.09 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | 1.08 |
| Interest Coverage | -71.59 |
Financial Efficiency
Return on Equity is -0.35% and Return on Invested Capital is 0.9%.
| Return on Equity | -0.35% |
| Return on Assets | -0.24% |
| Return on Invested Capital | 0.9% |
| Revenue Per Employee | $379.72K |
| Profits Per Employee | $-1.26K |
| Employee Count | 1,300 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | 5.88M |
| Effective Tax Rate | 138.53% |
Stock Price Statistics
The stock price has increased by 109.46% in the last 52 weeks. The beta is 1.03, so Inari Medical's price volatility has been higher than the market average.
| Beta | 1.03 |
| 52-Week Price Change | 109.46% |
| 50-Day Moving Average | 69.05 |
| 200-Day Moving Average | 52.77 |
| Relative Strength Index (RSI) | 79.6 |
| Average Volume (20 Days) | 2.44M |
Income Statement
In the last 12 months, Inari Medical had revenue of 493.63M and earned -1.64M in profits. Earnings per share was -0.03.
| Revenue | 493.63M |
| Gross Profit | 434.56M |
| Operating Income | -14.03M |
| Net Income | -1.64M |
| EBITDA | 15.19M |
| EBIT | 4.44M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 38.6M in cash and 32.05M in debt, giving a net cash position of 6.55M.
| Cash & Cash Equivalents | 38.6M |
| Total Debt | 32.05M |
| Net Cash | 6.55M |
| Retained Earnings | -48.49M |
| Total Assets | 697.24M |
| Working Capital | 114.61M |
Cash Flow
In the last 12 months, operating cash flow was 35.93M and capital expenditures -6.2M, giving a free cash flow of 29.73M.
| Operating Cash Flow | 35.93M |
| Capital Expenditures | -6.2M |
| Free Cash Flow | 29.73M |
| FCF Per Share | 0.52 |
Margins
Gross margin is 88.03%, with operating and profit margins of -2.84% and -0.33%.
| Gross Margin | 88.03% |
| Operating Margin | -2.84% |
| Pretax Margin | 0.86% |
| Profit Margin | -0.33% |
| EBITDA Margin | 3.08% |
| EBIT Margin | -2.84% |
| FCF Margin | 6.02% |
Dividends & Yields
NARI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.04% |
| FCF Yield | 0.81% |
Analyst Forecast
The average price target for NARI is $75, which is -6.2% lower than the current price. The consensus rating is "Hold".
| Price Target | $75 |
| Price Target Difference | -6.2% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
Scores
| Altman Z-Score | 11.23 |
| Piotroski F-Score | 2 |